StockData
Vaxcyte, Inc. logo

Vaxcyte, Inc. (PCVX) income statement

PCVXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$58.52−0.88 (-1.48%)

Close on Nov 18, 2026Market cap $8.71BP/E –Yield 0.00%

See a number that looks wrong?